Oxidative stress-induced corticosteroid insensitivity is reversed by formoterol via inhibition of PI3K signalling in peripheral blood mononuclear cells from patients with COPD and severe asthma Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011
The Cys-LT1 receptor antagonist, pranlukast, attenuates allergen-induced increase in airway eosinophils and bone marrow derived eosinophil/basophil progenitors in subjects with atopic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 349s Year: 2003
Formoterol enhances anti-inflammatory effects of corticosteroid in peripheral blood mononuclear cells from COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 215s Year: 2006
Formoterol, but not salmeterol, restores corticosteroid sensitivity in peripheral blood mononuclear cells from COPD via PI3K inhibition Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008
The effect of eosinophil subtypes on ASM cells proliferation and viability in asthma Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease Year: 2020
Interferon-β augments eosinophil adhesion-inducing activity of endothelial cells Source: Eur Respir J 2008; 32: 1540-1547 Year: 2008
A leukotriene antagonist, montelukast, reduces in vitro LTD4 increases in peripheral blood eosinophil progenitor colonies in atopic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001
EP4 agonist increases myeloid derived suppressor cells activity and reduces airway inflammatory events in a murine model of asthma Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020
Pentoxifylline (PTX) inhibits angiogenesis induced by human peripheral blood mononuclear cells (PBMC) and decreases the release of TNFα not influencing IFNγ release Source: Eur Respir J 2001; 18: Suppl. 33, 353s Year: 2001
In vivo allergen-activated inflammatory eosinophils reduced airway smooth muscle cells apoptosis in allergic asthma patients Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021
Distribution and degranulation of airway mast cells in normal and asthmatic subjects Source: Eur Respir J 2002; 19: 879-885 Year: 2002
The influence of gluco-corticoids (GC) on the apoptosis of activated cells in the induced sputum of patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002
Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells Source: Eur Respir J 2008; 31: 1313-1321 Year: 2008
Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012
Increased cytokine production by peripheral blood mononuclear cells (PBMC) and alveolar macrophages (AM) in active sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 177s Year: 2003
Infiltration of mast cells with increased IgE-receptor expression in peripheral lung of patients with uncontrolled asthma Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010
The PPARgamma agonist ciglitizone inhibits CXCL10 release by asthmatic and non-asthmatic airway smooth muscle cells Source: Eur Respir J 2006; 28: Suppl. 50, 339s Year: 2006
Adenosine, mast cells and mediators in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 548s Year: 2003
Resveratrol impairs cytokine release from human airway smooth muscle cells (HASMCs) and alveolar macrophages (AM) in COPD Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009
Glucocorticoid sensitivity of peripheral mononuclear cells in children with asthma Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008